Surgery, Gastroenterology and Oncology
Vol. 23, No. 5, Oct 2018
Minimally Invasive Locoregional Treatment of Intrahepatic Cholangiocellular Carcinoma
Daniel Putzer, Peter Schullian, Werner R. Jaschke, Reto Bale
REVIEW, Oct 2018
Article DOI: 10.21614/sgo-23-5-303
Surgical resection is considered first-line treatment for intrahepatic cholangiocellular carcinoma (ICC).
In case of a unresectable tumor, chemotherapy is part of standardized treatment guidelines, despite dismal outcome. Technical advances in locoregional therapies such as radiofrequency ablation, microwave ablation, irreversible electroporation, transarterial chemoembolization and selective internal radiation therapy bear the promise for enhancing local tumor control, while reducing treatment associated morbidity and improving survival as well asquality of life.
This review focuses on the latest improvements of minimally invasive locoregional therapies and their implementation in modern multimodality treatment protocols for ICC.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 3421

Cited by 1 articles

Journal: Research and Practical Medicine Journal (2410-1893)
Article: Combined treatment for locally advanced cholangiocellular liver cancer - the case report
Crossref DOI: 10.17709/2409-2231-2019-6-4-16

Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.